Aratana Therapeutics Inc.

aratana.com

Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for cats and dogs. Aratana is a fast-growing company headquartered in the greater Kansas City area focused on delivering safe and effective therapeutics that elevate the standard of care in veterinary medicine. As a pioneer in pet therapeutics, Aratana’s goal is to work with companion animal veterinarians to bring new therapeutics to market that support the needs of pets and their owners.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

KARYOPHARM RECEIVES FDA FAST TRACK DESIGNATION FOR SELINEXOR FOR THE TREATMENT OF MYELOFIBROSIS

PRNewswire | July 18, 2023

news image

Karyopharm Therapeutics Inc. a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to the development program of selinexor for the treatment of patients with myelofibrosis, including primary myelofibrosis, post-essential thrombocythemia myelofibrosis, and post-polycythemia vera myelofibrosis. "Fast Track Designation for selinexor highlights its...

Read More

Business Insights, PHARMA TECH

CERTARA ACQUIRES AI COMPANY VYASA TO BOOST SCIENTIFIC INNOVATION

Certara | January 05, 2023

news image

Certara, Inc. announced the acquisition of Vyasa Analytics, LLC, which offers scalable deep-learning software that enables life sciences enterprises to make predictions and answer complicated queries across structured and unstructured bio-medical data. The acquisition will improve Certara's software by giving its end-to-end platform cutting-edge artificial intelligence (AI) features. Certara said it was excited to announce that it had bought Vyasa, a cutting-edge company that ...

Read More

Business Insights

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

news image

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More

Business Insights

ANGELINI PHARMA, A NEW PARTNER IN EPILEPSY

Angelini Pharma | March 26, 2022

news image

On the occasion of Purple Day an annual international event aimed at raising awareness of epilepsy, Angelini Pharma, international Italian pharmaceutical company, is committed to provide patients and healthcare professionals with innovative solutions improving the care of patients with epilepsy. Epilepsy is a common neurological disorder that typically results in seizures of various types, with focal seizures being the most common one.1 The essential treatment goal of epilepsy the...

Read More
news image

Pharmacy Market

KARYOPHARM RECEIVES FDA FAST TRACK DESIGNATION FOR SELINEXOR FOR THE TREATMENT OF MYELOFIBROSIS

PRNewswire | July 18, 2023

Karyopharm Therapeutics Inc. a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to the development program of selinexor for the treatment of patients with myelofibrosis, including primary myelofibrosis, post-essential thrombocythemia myelofibrosis, and post-polycythemia vera myelofibrosis. "Fast Track Designation for selinexor highlights its...

Read More
news image

Business Insights, PHARMA TECH

CERTARA ACQUIRES AI COMPANY VYASA TO BOOST SCIENTIFIC INNOVATION

Certara | January 05, 2023

Certara, Inc. announced the acquisition of Vyasa Analytics, LLC, which offers scalable deep-learning software that enables life sciences enterprises to make predictions and answer complicated queries across structured and unstructured bio-medical data. The acquisition will improve Certara's software by giving its end-to-end platform cutting-edge artificial intelligence (AI) features. Certara said it was excited to announce that it had bought Vyasa, a cutting-edge company that ...

Read More
news image

Business Insights

GOODRX CLOSES ACQUISITION OF VITACARE, A TECH-ENABLED PHARMACY SERVICES PLATFORM

GoodRx | April 18, 2022

GoodRx, a leading consumer-focused digital healthcare platform announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition wil...

Read More
news image

Business Insights

ANGELINI PHARMA, A NEW PARTNER IN EPILEPSY

Angelini Pharma | March 26, 2022

On the occasion of Purple Day an annual international event aimed at raising awareness of epilepsy, Angelini Pharma, international Italian pharmaceutical company, is committed to provide patients and healthcare professionals with innovative solutions improving the care of patients with epilepsy. Epilepsy is a common neurological disorder that typically results in seizures of various types, with focal seizures being the most common one.1 The essential treatment goal of epilepsy the...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us